PMC:7441777 / 3309-3567 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":26,"end":34},"obj":"Body_part"},{"id":"T13","span":{"begin":187,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T23","span":{"begin":38,"end":46},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T20","span":{"begin":82,"end":90},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38","span":{"begin":26,"end":34},"obj":"Chemical"},{"id":"T39","span":{"begin":162,"end":169},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"109","span":{"begin":64,"end":65},"obj":"Gene"},{"id":"110","span":{"begin":78,"end":79},"obj":"Gene"},{"id":"111","span":{"begin":82,"end":90},"obj":"Gene"},{"id":"112","span":{"begin":92,"end":93},"obj":"Gene"},{"id":"113","span":{"begin":100,"end":112},"obj":"Gene"},{"id":"114","span":{"begin":114,"end":115},"obj":"Gene"},{"id":"115","span":{"begin":68,"end":76},"obj":"Gene"},{"id":"125","span":{"begin":38,"end":48},"obj":"Species"}],"attributes":[{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"Gene:43740568"},{"id":"A110","pred":"tao:has_database_id","subj":"110","obj":"Gene:43740570"},{"id":"A111","pred":"tao:has_database_id","subj":"111","obj":"Gene:43740571"},{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"Gene:43740571"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"Gene:43740575"},{"id":"A114","pred":"tao:has_database_id","subj":"114","obj":"Gene:43740575"},{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"Gene:43740570"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T32","span":{"begin":0,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There are four structural proteins in SARS-CoV-2, namely spike (S), envelope (E), membrane (M), and nucleocapsid (N), and all of them can potentially serve as an antigen for neutralizing antibody preparation as potential therapeutics (Boopathi et al., 2020)."}